October 24th, 2019 4:40 PM by Shane Greene
There is currently no drug treatments on the market that can slow the progression of Alzheimer’s disease—but this new medication could soon be a groundbreaking treatment for dementia patients after researchers examined the data from the drug’s Phase 3 clinical trials.
This week, pharmaceutical company Biogen...Read more